The mTOR pathway has previously been shown to be important for polarity-impaired Ras-driven tumour growth in Drosophila (Willecke et al., 2011), and its inhibition by trametinib that we observed in our study is likely to contribute to the G1 cell cycle arrest observed upon trametinib treatment. Here, MTOR is linked to neoplasm.